CAPN1 is a novel biomaker of patients with AML based on comprehensive analysis
{{output}}
Acute myeloid leukemia (AML) is a common hematologic malignancy in adults. Recent studies investigating the potential pathogenesis of AML have significantly advanced our understanding of this disease. While cytogenetics and molecular abnormalities are crucial ... ...